FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3126758740> ?p ?o ?g. }

• W3126758740 endingPage "e0244510" @default.
• W3126758740 startingPage "e0244510" @default.
• W3126758740 abstract "The association between bladder cancer mortality-to-incidence ratios (MIRs) and healthcare disparities has gender differences. However, no evidence supports gender as an issue in the association between changes in the MIR and health expenditures on bladder cancer. Changes in the MIR were defined as the difference in data from the years 2012 and 2018, which was named δMIR. Current health expenditures (CHE) and the human development index (HDI) were obtained from the World Health Organization and the Human Development Report Office. The association between variables was analyzed by Spearman’s rank correlation coefficient. In total, 55 countries were analyzed according to data quality and the exclusion of missing data. Globally, the MIR changed according to the HDI level in both genders. Among the 55 countries studied, a high HDI and CHE were significantly associated with a favorable age-standardized rate-based MIR (ASR-based MIR) in both genders and the subgroups according to gender (for both genders, MIR vs. HDI: ρ = -0.720, p < 0.001; MIR vs. CHE per capita: ρ = -0.760, p < 0.001; MIR vs. CHE as a percentage of gross domestic product (CHE/GDP): ρ = -0.663, p < 0.001). Importantly, in females only, the CHE/GDP but neither the HDI score nor the CHE per capita was significantly associated with a favorable ASR-based δMIR (ASR-based δMIR vs. CHE/GDP: ρ = 0.414, p = 0.002). In the gender subgroups, the association between the HDI and the CHE was statistically significant for females and less significant for males. In conclusion, favorable bladder ASR-based MIRs were associated with a high CHE; however, improvement of the ASR-based δMIR data was more correlated with the CHE in females. Further investigation of the gender differences via a cohort survey with detailed information of clinical-pathological characteristics, treatment strategies, and outcomes might clarify these issues and improve therapeutic and/or screening strategies for bladder cancer." @default.
• W3126758740 created "2021-02-15" @default.
• W3126758740 creator A5003548884 @default.
• W3126758740 creator A5020702263 @default.
• W3126758740 creator A5030332628 @default.
• W3126758740 creator A5038410134 @default.
• W3126758740 creator A5059705709 @default.
• W3126758740 creator A5071263900 @default.
• W3126758740 date "2021-02-12" @default.
• W3126758740 modified "2023-09-30" @default.
• W3126758740 title "Gender differences in trends of bladder cancer mortality-to-incidence ratios according to health expenditure in 55 countries" @default.
• W3126758740 cites W1271572098 @default.
• W3126758740 cites W1544285763 @default.
• W3126758740 cites W1974386050 @default.
• W3126758740 cites W1982719862 @default.
• W3126758740 cites W2035791309 @default.
• W3126758740 cites W2167087050 @default.
• W3126758740 cites W2172219600 @default.
• W3126758740 cites W2314974605 @default.
• W3126758740 cites W2317091748 @default.
• W3126758740 cites W2571168471 @default.
• W3126758740 cites W2655572749 @default.
• W3126758740 cites W2783414919 @default.
• W3126758740 cites W2885997681 @default.
• W3126758740 cites W2889646458 @default.
• W3126758740 cites W2892569486 @default.
• W3126758740 cites W2903703298 @default.
• W3126758740 cites W2921889743 @default.
• W3126758740 cites W2934807470 @default.
• W3126758740 cites W3104963805 @default.
• W3126758740 doi "https://doi.org/10.1371/journal.pone.0244510" @default.
• W3126758740 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7880433" @default.
• W3126758740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33577604" @default.
• W3126758740 hasPublicationYear "2021" @default.
• W3126758740 type Work @default.
• W3126758740 sameAs 3126758740 @default.
• W3126758740 citedByCount "2" @default.
• W3126758740 countsByYear W31267587402022 @default.
• W3126758740 countsByYear W31267587402023 @default.
• W3126758740 crossrefType "journal-article" @default.
• W3126758740 hasAuthorship W3126758740A5003548884 @default.
• W3126758740 hasAuthorship W3126758740A5020702263 @default.
• W3126758740 hasAuthorship W3126758740A5030332628 @default.
• W3126758740 hasAuthorship W3126758740A5038410134 @default.
• W3126758740 hasAuthorship W3126758740A5059705709 @default.
• W3126758740 hasAuthorship W3126758740A5071263900 @default.
• W3126758740 hasBestOaLocation W31267587401 @default.
• W3126758740 hasConcept C101601086 @default.
• W3126758740 hasConcept C105795698 @default.
• W3126758740 hasConcept C114350782 @default.
• W3126758740 hasConcept C120665830 @default.
• W3126758740 hasConcept C121332964 @default.
• W3126758740 hasConcept C121608353 @default.
• W3126758740 hasConcept C126322002 @default.
• W3126758740 hasConcept C127598652 @default.
• W3126758740 hasConcept C144024400 @default.
• W3126758740 hasConcept C149923435 @default.
• W3126758740 hasConcept C159744936 @default.
• W3126758740 hasConcept C162324750 @default.
• W3126758740 hasConcept C17744445 @default.
• W3126758740 hasConcept C179755657 @default.
• W3126758740 hasConcept C199539241 @default.
• W3126758740 hasConcept C2779735493 @default.
• W3126758740 hasConcept C2780352672 @default.
• W3126758740 hasConcept C2781089502 @default.
• W3126758740 hasConcept C2908647359 @default.
• W3126758740 hasConcept C33923547 @default.
• W3126758740 hasConcept C50522688 @default.
• W3126758740 hasConcept C61511704 @default.
• W3126758740 hasConcept C71924100 @default.
• W3126758740 hasConcept C99454951 @default.
• W3126758740 hasConceptScore W3126758740C101601086 @default.
• W3126758740 hasConceptScore W3126758740C105795698 @default.
• W3126758740 hasConceptScore W3126758740C114350782 @default.
• W3126758740 hasConceptScore W3126758740C120665830 @default.
• W3126758740 hasConceptScore W3126758740C121332964 @default.
• W3126758740 hasConceptScore W3126758740C121608353 @default.
• W3126758740 hasConceptScore W3126758740C126322002 @default.
• W3126758740 hasConceptScore W3126758740C127598652 @default.
• W3126758740 hasConceptScore W3126758740C144024400 @default.
• W3126758740 hasConceptScore W3126758740C149923435 @default.
• W3126758740 hasConceptScore W3126758740C159744936 @default.
• W3126758740 hasConceptScore W3126758740C162324750 @default.
• W3126758740 hasConceptScore W3126758740C17744445 @default.
• W3126758740 hasConceptScore W3126758740C179755657 @default.
• W3126758740 hasConceptScore W3126758740C199539241 @default.
• W3126758740 hasConceptScore W3126758740C2779735493 @default.
• W3126758740 hasConceptScore W3126758740C2780352672 @default.
• W3126758740 hasConceptScore W3126758740C2781089502 @default.
• W3126758740 hasConceptScore W3126758740C2908647359 @default.
• W3126758740 hasConceptScore W3126758740C33923547 @default.
• W3126758740 hasConceptScore W3126758740C50522688 @default.
• W3126758740 hasConceptScore W3126758740C61511704 @default.
• W3126758740 hasConceptScore W3126758740C71924100 @default.
• W3126758740 hasConceptScore W3126758740C99454951 @default.
• W3126758740 hasFunder F4320334933 @default.
• W3126758740 hasIssue "2" @default.
• W3126758740 hasLocation W31267587401 @default.

• next